Page last updated: 2024-11-01

niclosamide and Adenomatous Polyposis Coli, Familial

niclosamide has been researched along with Adenomatous Polyposis Coli, Familial in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
"Niclosamide treatment successfully attenuates Snail abundance while increasing E-cadherin abundance in xenograft tumor."1.46Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction. ( Ahn, SY; Cha, JS; Cha, SY; Cha, YH; Cho, ES; Cho, HS; Cho, S; Choi, J; Jeon, Y; Kim, HS; Kim, NH; Lee, H; Lee, K; Lee, Y; No, KT; Yang, JH; Yook, JI; Yuk, YS, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, SY1
Kim, NH1
Lee, K1
Cha, YH1
Yang, JH1
Cha, SY1
Cho, ES1
Lee, Y1
Cha, JS1
Cho, HS1
Jeon, Y1
Yuk, YS1
Cho, S1
No, KT1
Kim, HS1
Lee, H1
Choi, J1
Yook, JI1

Other Studies

1 other study available for niclosamide and Adenomatous Polyposis Coli, Familial

ArticleYear
Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction.
    Oncotarget, 2017, May-09, Volume: 8, Issue:19

    Topics: Adenomatous Polyposis Coli; Animals; Axin Protein; Cell Line, Tumor; Cell Movement; Cell Survival; D

2017